Jubilant Pharmova Overview

  • Year Founded
  • 1978

Year Founded

  • Status
  • Public

  • Employees
  • 1,034

Employees

  • Stock Symbol
  • 530019

Stock Symbol

  • Investments
  • 15

  • Share Price
  • $5.12
  • (As of Thursday Closing)

Jubilant Pharmova General Information

Description

Jubilant Pharmova Ltd is an integrated global pharmaceutical company. The company's segment includes Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment. Geographically, it derives a majority of its revenue from Americas and Europe.

Contact Information

Website
www.jubilantpharmova.com
Formerly Known As
Jubilant Life Sciences Ltd, Vam Organic Chemicals
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
BOM
Primary Office
  • 1A, Sector 16A
  • Noida, 201301
  • India
+91 0120 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jubilant Pharmova Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.12 $5.12 $3.27 - $5.86 $815M 159M 25.1K -$0.08

Jubilant Pharmova Financials Summary

In Thousands,
USD 		TTM 30-Jun-2023 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021
EV 1,083,039 850,480 1,084,456 1,841,738
Revenue 778,125 774,529 813,228 801,597
EBITDA 87,534 92,228 154,070 199,998
Net Income (12,462) (7,594) 55,556 112,348
Total Assets 1,358,893 1,317,564 1,214,244
Total Debt 0 447,834 420,951 385,259
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Jubilant Pharmova Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Jubilant Pharmova‘s full profile, request access.

Request a free trial

Jubilant Pharmova Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Jubilant Pharmova Ltd is an integrated global pharmaceutical company. The company's segment includes Radiopharma; Allerg
Pharmaceuticals
Noida, India
1,034 As of 2023
00000
0000 0000-00-00
00000000000 00000

000000

t, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
000000000000000
Bangalore, India
0000 As of 0000
000.00
000000000 000.00

000000

amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore e
0000 000000000
Mumbai, India
000 As of 0000
0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Jubilant Pharmova Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Strides Pharma Science Corporation Bangalore, India 0000 000.00 000000000 000.00
00000000 000000 Corporation Mumbai, India 000 0000
00000000 Corporation Basel, Switzerland 000000 0000 000000000 0000
00000 Corporation Mumbai, India 00000 0&0
00000000 000000000 Corporation Mumbai, India 00000 00000 000000000 00000
You’re viewing 5 of 33 competitors. Get the full list »

Jubilant Pharmova Patents

  • 19

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Jubilant Pharmova Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3534708-A1 Synergistic antimicrobial compositions Inactive 07-Nov-2016 000000000
US-20190350200-A1 Synergistic antimicrobial compositions Inactive 07-Nov-2016 000000000
US-20160374914-A2 Anti-dandruff compositions and hair care formulations containing zinc pyrithione and quaternary ammonium salt Active 06-Sep-2013 00000000 0
EP-3041356-A1 Anti-dandruff compositions and hair care formulations containing zinc pyrithione and quaternary ammonium salt Active 06-Sep-2013 00000000
US-9968537-B2 Anti-dandruff compositions and hair care formulations containing zinc pyrithione and quaternary ammonium salt Inactive 06-Sep-2013 A61K8/58
To view Jubilant Pharmova’s complete patent history, request access »

Jubilant Pharmova Executive Team (24)

Name Title Board Seat Contact Info
Giuliano Perfetti Chief Executive Officer, Jubilant Biosys Limited and API & CDMO
Arvind Chokhany Chief Financial Officer, Finance & Board Member
Rohini Seth Chief Human Resources Officer
Sudha Pillai Director
R. Sankaraiah Executive Director- Finance
You’re viewing 5 of 24 executive team members. Get the full list »

Jubilant Pharmova Board Members (7)

Name Representing Role Since
0000 0000 Self Board Member 000 0000
000000 00000000 Jubilant Pharmova Chief Financial Officer, Finance & Board Member 000 0000
0000 0000000 Self Board Member & Chairman 000 0000
0. 0000000 Jubilant Pharmova Board Member 000 0000
00000 0000000 Self Chairman & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Jubilant Pharmova Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jubilant Pharmova Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Jubilant Pharmova‘s full profile, request access.

Request a free trial

Jubilant Pharmova Investments & Acquisitions (15)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 01-Apr-2022 00000 0000 00.000 Personal Products
0000 00000 01-Nov-2021 000000000 Other Agriculture
000000 00000 01-Jan-2021 000000000 00000 Buildings and Property
00000000 11-Nov-2020 00000 0000 0000 Biotechnology
Jubilant Radiopharma 01-Sep-2017 Merger/Acquisition 000.00 Pharmaceuticals 000000000
You’re viewing 5 of 15 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Jubilant Pharmova Subsidiaries (3)

Company Name Industry Location Founded
Jubilant Radiopharma Pharmaceuticals Yardley, PA 2007
0000000 00000000 Pharmaceuticals Yardley, PA 0000
00000000000000 000 Pharmaceuticals Spokane, WA 0000
To view Jubilant Pharmova’s complete subsidiaries history, request access »

Jubilant Pharmova ESG

Risk Overview

Risk Rating

Updated December, 13, 2022

30.19 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,491

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 871

Rank

00.00

Percentile

Pharmaceuticals

Subindustry

00 of 415

Rank

00.00

Percentile

To view Jubilant Pharmova’s complete esg history, request access »

Jubilant Pharmova Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 00000 01-Nov-2021 000000000 Completed
  • 00000000 00000000
Insilco 19-Oct-1988 Joint Venture Completed
  • 2 buyers
To view Jubilant Pharmova’s complete exits history, request access »